Summary
Five patients with drug-induced agranulocytosis received 300μg recombinant human granulocyte colony-stimulating factor (rh G-CSF) subcutaneously twice daily for 2–5 days. G-CSF therapy resulted in a steep increase of the neutrophil count, which was faster than that in patients with spontaneous recovery reported in the literature. In all four patients with infectious complications fever rapidly declined with the increase of granulocytes. G-CSF may be useful in the management of drug-induced agranulocytosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abt C, Dietrich M, Niethammer D, Arnold R, Pflieger H, Töllner U, Vanek E, Kubanek B, Kleihauer E, Heimpel H (1978) Akute arzneimittelinduzierte Agranulozytose. Dtsch Med Wochenschr 103: 108–114
Delannoy A, Gehenot M (1989) Colony-stimulating factor and drug-induced agranulocytosis. Ann Intern Med 110: 942–943
Furukawa T, Takahashi M, Moriyama Y, Koike T, Kurokawa I, Shibata A (1991) Successful treatment of chronic idiopathic neutropenia using recombinant granulocyte colony-stimulating factor. Ann Hematol 62: 22–24
Heimpel H, Abt C (1979) Medikamente und akute Agranulocytose. Dtsch Med Wochenschr 104: 731–736
Heit W, Heimpel H, Frickhofen N (1985) Drug-induced agranulocytosis: evidence for the commitment of bone marrow haematopoiesis. Scand J Haematol 35: 459–468
Julia A, Olona M, Bueno J, Revilla E, Rosello J, Petit J, Morey M, Flores A, Font L, Macia J (1991) Drug-induced agranulocytosis: prognostic factors in a series of 168 episodes. Br J Haematol 79: 366–371
Lieschke GJ, Burgess AW (1992) Granulocyte colony-stimulating factor and macrophage colony-stimulating factor. N Engl J Med 326: 28–30
Lieschke GJ, Burgess AW (1992) Granulocyte colony-stimulating factor and macrophage colony-stimulating factor. N Engl J Med 327: 99–101
Lindemann A, Herrmann F, Oster W, Haffner G, Meyenburg W, Souza LM, Mertelsmann R (1989) Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood 74: 2644–2651
Lord B, Bronchud M, Owens S, Chang J, Howell H, Souza L, Dexter TM (1989) The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc Natl Acad Sci USA 86: 94–99
Muroi K, Ito M, Sasaki R, Suda T, Sakamoto S, Miura Y (1989) Treatment of drug-induced agranulocytosis with granulocytecolony stimulating factor. Lancet 2: 55
Nand S, Bayer R, Prinz RA, Feiten W, Godwin JE (1991) Granulocyte-macrophage colony-stimulating factor for the treatment of drug-induced agranulocytosis. Am J Hematol 37: 267–269
Pambald J, Jonson B, Kanerud L (1990) Case report: treatment of drug-induced agranulocytosis with recombinant GM-CSF. J Intern Med 228: 537–539
Patton WN, Holyoake TL, Yates JM, Boughton R, Franklin IM (1992) Accelerated recovery from drug-induced agranulocytosis following G-CSF therapy. Br J Haematol 80: 564–565
Wallach FR, Zirn J, Murray HW, Tepler J, Luger NW (1991) Use of granulocyte-macrophage colony-stimulating factor for treatment of drug-induced agranulocytosis. Rev Infect Dis 13: 523
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Willfort, A., Lorber, C., Kapiotis, S. et al. Treatment of drug-induced agranulocytosis with recombinant granulocyte colony-stimulating factor (rh G-CSF). Ann Hematol 66, 241–244 (1993). https://doi.org/10.1007/BF01738472
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01738472